We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Structural Studies Reveal Molecular Basis for Bacterial Motility in the Urinary Tract

By LabMedica International staff writers
Posted on 23 Mar 2016
Print article
Image: Using the protein FimH (yellow/red) located at the tip of long protrusions, the bacterial pathogen E. coli (grey) attaches to cell surfaces of the urinary tract (Photo courtesy of Maximilian Sauer, ETH Zürich).
Image: Using the protein FimH (yellow/red) located at the tip of long protrusions, the bacterial pathogen E. coli (grey) attaches to cell surfaces of the urinary tract (Photo courtesy of Maximilian Sauer, ETH Zürich).
A team of molecular microbiologists has unraveled the mechanism used by Escherichia coli bacteria to bind to cells lining the urinary tract and explained how the pathogen migrates to the bladder despite the strong force of urine flowing in the other direction.

E. coli attaches to host epithelia via the fimbrial adhesion FimH, a two-domain protein at the tip of type I pili recognizing terminal mannoses on epithelial glycoproteins.

Investigators at the University of Basel (Switzerland) and ETH Zurich (Switzerland) established a model system for fimbrial FimH function. A fimbril is a proteinaceous appendage in many gram-negative bacteria that is thinner and shorter than a flagellum.

The investigators revealed, in a paper published in the March 7, 2016, online edition of the journal Nature Communications, a three-state mechanism of FimH catch-bond formation based on crystal structures of all states, kinetic analysis of ligand interaction, and molecular dynamics simulations. They found that FimH bound to sugar structures on the cell surface increasingly tightly the more it was pulled. As strong tensile forces developed during urination, FimH protected the bacteria from being flushed out. In the absence of tensile force, the FimH pilin domain allosterically accelerated spontaneous ligand dissociation from the FimH lectin domain by 100,000-fold, resulting in weak affinity and allowing the bacteria to release from the cell surface and migrate in the direction of the bladder.

“Through the combination of several biophysical and biochemical methods, we have been able to elucidate the binding behavior of FimH in more detail than ever before”, said senior author Dr. Rudolf Glockshuber, professor of molecular biology and biophysics at ETH Zurich. “The protein FimH is composed of two parts, of which the second non-sugar binding part regulates how tightly the first part binds to the sugar molecule. When the force of the urine stream pulls apart the two protein domains, the sugar binding site snaps shut. However, when the tensile force subsides, the binding pocket reopens. Now the bacteria can detach and swim upstream the urethra.”

Related Links:
University of Basel
ETH Zurich


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.